Spots Global Cancer Trial Database for acute lymphoblastic leukemia, pediatric
Every month we try and update this database with for acute lymphoblastic leukemia, pediatric cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Low GI Diet in Children and Adolescents With ALL | NCT03157323 | Acute Lymphobla... Obesity, Pediat... | Low Glycemic In... | 5 Years - 21 Years | Columbia University | |
| The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China | NCT04228393 | Acute Lymphobla... | 6-mercaptopurin... Standard treatm... Individualized ... | 1 Year - 18 Years | Shandong University | |
| Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells. | NCT06334835 | Acute Lymphobla... | lncRNA signatur... | 1 Year - 18 Years | IRCCS SYNLAB SDN | |
| Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia | NCT04770922 | Acute Lymphobla... Adverse Drug Ev... | - 21 Years | Cipherome, Inc. | ||
| Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR | NCT03676504 | Acute Lymphobla... Acute Lymphobla... Chronic Lymphoc... Diffuse Large B... Follicular Lymp... Mantle Cell Lym... | CD19.CAR T Cell... Fludarabine Cyclophosphamid... | 3 Years - | University Hospital Heidelberg | |
| MRD Detection by NGS in Pediatric B-ALL | NCT05973032 | Acute Lymphobla... | MRD | - 18 Years | The Children's Hospital of Zhejiang University School of Medicine | |
| Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL) | NCT03035344 | Acute Lymphobla... Metabolism Diso... | Metabolome stud... | 1 Month - 16 Years | Aristotle University Of Thessaloniki | |
| Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3 | NCT06074666 | Acute Lymphobla... | CareMeds Interv... Usual Care Grou... | 3 Years - 9 Years | Roswell Park Cancer Institute | |
| Biology and Benefits of Music Play and Stories for Kids/Parents During ALL Treatment | NCT04400071 | Acute Lymphobla... Pediatric Cance... | Active Music En... Audio Storybook... | 3 Years - 8 Years | Indiana University | |
| Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | NCT03020030 | Acute Lymphobla... | Pegaspargase Erwinia asparag... Cyclophosphamid... CYTARABINE DASATINIB DEXAMETHASONE Dexrazoxane Doxorubicin ETOPOSIDE HYDROCORTISONE LEUCOVORIN CALC... MERCAPTOPURINE METHOTREXATE NELARABINE Vincristine | 1 Year - 21 Years | Dana-Farber Cancer Institute | |
| CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies | NCT04088864 | B Cell Lymphoma Acute Lymphobla... Lymphoma | Fludarabine Cyclophosphamid... Autologous CD22... | 1 Year - 30 Years | Stanford University | |
| Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors | NCT04472286 | Acute Lymphobla... Pediatric ALL Pediatric Lymph... Bone Loss Metabolic Syndr... Habitual Physic... Precursor Cell ... Lymphoma Leukemia Lymphoid Leukem... Pediatric Osteoporosis Osteoporosis Ri... | 5 Years - 18 Years | University of Nebraska | ||
| Parental Perception of Their Child's Emotional Quality of Life in Paediatric Oncology Before and After "Magic Massages" | NCT06107478 | Acute Lymphobla... | Self-report que... Interview (only... Clinical data c... | 2 Years - | Centre Leon Berard | |
| Vaccine Immune Recovery After Leukemia | NCT05622682 | Acute Lymphobla... | Observational o... | 3 Years - 31 Years | Children's Hospital of Philadelphia | |
| Determining the Mechanisms of Loss of CAR T Cell Persistence | NCT05809284 | Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... | - 25 Years | University College, London | ||
| Low GI Diet in Children and Adolescents With ALL | NCT03157323 | Acute Lymphobla... Obesity, Pediat... | Low Glycemic In... | 5 Years - 21 Years | Columbia University | |
| Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation | NCT05837689 | Acute Lymphobla... | Blinatumomab | 1 Year - 18 Years | The Children's Hospital of Zhejiang University School of Medicine | |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 | NCT03643276 | Acute Lymphobla... | Blinatumomab Bortezomib Cyclophosphamid... Cytarabine Daunorubicin Myocet Dexamethasone Doxorubicin Etoposide Fludarabine Pho... Ifosfamide 6-Mercaptopurin... Methotrexate Pegaspargase Prednisolone Tioguanin Vincristine Vindesine Erwinase | - 17 Years | University Hospital Schleswig-Holstein | |
| The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China | NCT04228393 | Acute Lymphobla... | 6-mercaptopurin... Standard treatm... Individualized ... | 1 Year - 18 Years | Shandong University | |
| Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells. | NCT06334835 | Acute Lymphobla... | lncRNA signatur... | 1 Year - 18 Years | IRCCS SYNLAB SDN | |
| Physical Exercise and Dairy Probiotics in Childhood Cancer Survivors | NCT05939791 | Acute Lymphobla... | Lacticaseibacil... Physical exerci... | 6 Years - 12 Years | Comenius University | |
| Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia | NCT04770922 | Acute Lymphobla... Adverse Drug Ev... | - 21 Years | Cipherome, Inc. | ||
| Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL) | NCT03035344 | Acute Lymphobla... Metabolism Diso... | Metabolome stud... | 1 Month - 16 Years | Aristotle University Of Thessaloniki | |
| Determining the Mechanisms of Loss of CAR T Cell Persistence | NCT05809284 | Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... | - 25 Years | University College, London | ||
| Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | NCT03020030 | Acute Lymphobla... | Pegaspargase Erwinia asparag... Cyclophosphamid... CYTARABINE DASATINIB DEXAMETHASONE Dexrazoxane Doxorubicin ETOPOSIDE HYDROCORTISONE LEUCOVORIN CALC... MERCAPTOPURINE METHOTREXATE NELARABINE Vincristine | 1 Year - 21 Years | Dana-Farber Cancer Institute | |
| Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021) | NCT05029531 | Acute Lymphobla... ALL, Infants | the risk-adapte... | 1 Day - 365 Days | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | |
| Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR | NCT03676504 | Acute Lymphobla... Acute Lymphobla... Chronic Lymphoc... Diffuse Large B... Follicular Lymp... Mantle Cell Lym... | CD19.CAR T Cell... Fludarabine Cyclophosphamid... | 3 Years - | University Hospital Heidelberg | |
| Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea | NCT06257394 | Acute Lymphobla... | Dasatinib(Spryc... Non-Dasatinib(S... | 1 Year - 19 Years | Seoul National University Hospital | |
| Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children | NCT04325841 | Acute Lymphobla... Acute Lymphobla... Refractory Acut... | Murine autologo... | 0 Years - 18 Years | Beijing Boren Hospital | |
| Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors | NCT04472286 | Acute Lymphobla... Pediatric ALL Pediatric Lymph... Bone Loss Metabolic Syndr... Habitual Physic... Precursor Cell ... Lymphoma Leukemia Lymphoid Leukem... Pediatric Osteoporosis Osteoporosis Ri... | 5 Years - 18 Years | University of Nebraska | ||
| Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation | NCT05837689 | Acute Lymphobla... | Blinatumomab | 1 Year - 18 Years | The Children's Hospital of Zhejiang University School of Medicine | |
| International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia | NCT03705507 | Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... Acute Lymphobla... | Selumetinib Dexamethasone | - | University of Birmingham |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
